» Articles » PMID: 30650119

Trends in the Risk of Myocardial Infarction Among HIV-1-infected Individuals Relative to the General Population in France: Impact of Gender and Immune Status

Abstract

We examined trends in the MI incidence and age at MI diagnosis among adults living with HIV-1 between 2000 and 2009, by comparison with the French MI registries, by gender. Age standardized incidence rates and standardized incidence-ratios (SIRs) were estimated for individuals included in the French hospital database on HIV (n = 71 204, MI = 663) during three periods: 2000-2002, 2003-2005 and 2006-2009. Median ages at MI diagnosis were compared using the Brown-Mood test. Over the study periods, the absolute rate difference and relative risks were higher in women than in men in 2000-2002 and 2006-2009, with respective SIRs 1.99 (1.39-2.75) and 1.12 (0.99-1.27) in 2006-2009. The trends were different for men and women with a decreasing trend in SIRs in men and no change in women. In both sexes, among individuals with CD4 ≥500/μL and controlled viral-load on cART, the risk was no longer elevated. Age at MI diagnosis was significantly younger than in the general population, especially among women (-6.2 years, p<0.001; men: -2.1 years, p = 0.02). In HIV-1-positive adults, absolute rate difference and relative risks and trends of MI were different between men and women and there was no additional risk among individuals on effective cART.

Citing Articles

First-ever acute ischemic strokes in HIV-infected persons: A case-control study from stroke units.

Stammler R, Guillaume J, Mazighi M, Denier C, Raynouard I, Lapergue B Ann Clin Transl Neurol. 2024; 11(4):916-925.

PMID: 38287505 PMC: 11021677. DOI: 10.1002/acn3.52008.


Risk of Myocardial Infarction in HIV Patients: A Systematic Review.

Alsheikh M, Alsheikh A Cureus. 2022; 14(11):e31825.

PMID: 36440301 PMC: 9683467. DOI: 10.7759/cureus.31825.


HIV and cardiovascular disease.

So-Armah K, Benjamin L, Bloomfield G, Feinstein M, Hsue P, Njuguna B Lancet HIV. 2020; 7(4):e279-e293.

PMID: 32243826 PMC: 9346572. DOI: 10.1016/S2352-3018(20)30036-9.


Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders.

Moulignier A, Costagliola D Curr Top Behav Neurosci. 2020; 50:367-399.

PMID: 31989463 DOI: 10.1007/7854_2019_123.

References
1.
Klein D, Leyden W, Xu L, Chao C, Horberg M, Towner W . Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis. 2015; 60(8):1278-80. DOI: 10.1093/cid/civ014. View

2.
Freiberg M, Chang C, Kuller L, Skanderson M, Lowy E, Kraemer K . HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013; 173(8):614-22. PMC: 4766798. DOI: 10.1001/jamainternmed.2013.3728. View

3.
Monforte A, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S . Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events. AIDS. 2013; 27(3):407-15. DOI: 10.1097/QAD.0b013e32835b2ef1. View

4.
Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L . HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012; 55(4):600-7. DOI: 10.1093/cid/cis489. View

5.
Chaturvedi A, Mbulaiteye S, Engels E . Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol. 2007; 18(3):230-4. DOI: 10.1016/j.annepidem.2007.10.005. View